Teva Pharmaceutical Industries (NYSE:TEVA) shareholders are up 5.9% this past week, but still in the red over the last five years - Simply Wall St News
![Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire](https://mms.businesswire.com/media/20230510005122/en/739014/5/teva_RGB_JPEG.jpg)
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire
![Marksans stock price: Marksans stock zooms 12% after news of Tevapharm facility buy - The Economic Times Marksans stock price: Marksans stock zooms 12% after news of Tevapharm facility buy - The Economic Times](https://m.economictimes.com/thumb/msid-94807521,width-1200,height-900,resizemode-4,imgsize-30910/marksans-pharma-to-acquire-tevapharm-india-goa-based-bulk-pharmaceutical-formulations-business.jpg)
Marksans stock price: Marksans stock zooms 12% after news of Tevapharm facility buy - The Economic Times
![DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall | Stock News & Stock Market Analysis - IBD DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall | Stock News & Stock Market Analysis - IBD](https://www.investors.com/wp-content/uploads/2016/12/IT19_esrx_121416_adobe.jpg)